TITLE

Retroperitoneal and Visceral Sarcomas: Issues for the General Surgeon

AUTHOR(S)
Woodall, Charles E.; Scoggins, Charles R.
PUB. DATE
June 2007
SOURCE
American Surgeon;Jun2007, Vol. 73 Issue 6, p631
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Sarcomas represent a rare, heterogeneous group of malignant tumors that arise from the mesenchymal tissues of the body. Although infrequently encountered, these tumors generate vigorous academic interest and an ever-expanding volume of medical literature. Chemotherapy is widely regarded as ineffective because of the often-large tumor burden and lack of good therapeutic drugs. Radiation therapy is often difficult to administer because of locoregional toxicity. Fortunately, targeted immunologic therapies have shown promise in some specific gastrointestinal mesenchymal tumors. To date, sarcoma remains a malignancy best treated operatively. Given the wide heterogeneity and biology of these tumors and the amount of new data available, a review of the current literature is warranted. The first installment of this review series dealt with extremity and trunk soft tissue sarcomas; this one will focus on retroperitoneal and visceral sarcomas and the management challenges they pose.
ACCESSION #
25515619

 

Related Articles

  • Clinical Outcomes of Intraoperative Radiation Therapy for Extremity Sarcomas. Tran, Quy N. H.; Kim, Anne C.; Gottschalk, Alexander R.; Wara, William M.; Phillips, Theodore L.; O'Donnell, Richard J.; Weinberg, Vivian; Haas-Kogan, Daphne A. // Sarcoma;2006, Vol. 2006, p1 

    Radiation of extremity lesions, a key component of limb-sparing therapy, presents particular challenges, with significant risks of toxicities. We sought to explore the efficacy of intraoperative radiation therapy (IORT) in the treatment of soft tissue sarcomas of the extremities. Patients....

  • Intensified adjuvant IFADIC chemotherapy in combination with radiotherapy versus radiotherapy alone for soft tissue sarcoma: long-term follow-up of a prospective randomized feasibility trial. Fakhrai, Negar; Ebm, Claudia; Kostler, Wolfgang J.; Jantsch, Marion; Abdolvahab, Farshid; Dominkus, Martin; Pokrajac, Boris; Kauer-Dorner, Daniela; Zielinski, Christoph C.; Brodowicz, Thomas // Wiener Klinische Wochenschrift;Nov2010, Vol. 122 Issue 21/22, p614 

    djuvant chemotherapy for grade 2 and 3 soft tissue sarcoma (STS) patients still has to be considered experimental. Fifty-nine patients underwent primary surgery by wide or marginal excision and were subsequently randomized to receive radiotherapy alone or in combination with six courses of...

  • Blood transfusion requirements for patients with sarcomas undergoing combined radio- and chemotherapy. Sherbourne, Karen R.; Earl, Helena M.; Whitehead, Lynne; Jefferies, Sarah J.; Burnet, Neil G. // Sarcoma;Sep-Dec2005, Vol. 9 Issue 3/4, p119 

    Patients with bony and soft tissue sarcomas may require intensive treatment with chemotherapy and radiotherapy, which often leads to a fall in haemoglobin levels, requiring blood transfusion. There may be advantages in predicting which patients will require transfusion, partly because anaemia...

  • Pattern of local recurrence after conservative surgery and radiotherapy for soft tissue sarcoma. Cleator, Susan J.; Cottrill, Chris; Harmer, Clive // Sarcoma;Jun2001, Vol. 5 Issue 2, p83 

    Purpose: Over the past three decades our centre has adopted a policy of conservative surgery followed by adjuvant radicaldose radiotherapy for medium- and high-grade soft tissue sarcomas. For all cases of local recurrence following this treatment we aimed to define the spatial relationship...

  • EORTC Group phase II study of oral etoposide for pretreated soft. Keizer, H. Jan; Crowther, Derek; Nielsen, Ole Steen; Oosterom, Allan T. Van; Muguiro, Javier Hornedo; Pottelberghe, Christine Van; Somers, Renier; Tursz, Thomas // Sarcoma;Jun1997, Vol. 1 Issue 2, p99 

    Purpose. This study investigates the efficacy and toxicity of daily oral etoposide in chemotherapy for non-heavily pretreated advanced and metastatic soft tissue sarcoma (STS). Subjects. Twenty-seven patients with progressive and measurable disease were treated. Median age was 53 years (range...

  • Diagnosis and management of soft tissue sarcoma. Sinha, Shiba; Peach, A. Howard S. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/15/2011, Vol. 342 Issue 7789, p157 

    The article offers clinical information on soft tissue sarcoma, a heterogeneous group of tumors of mesodermal origin. Soft tissue sarcoma may occur at any age, with rhabdomyosarcoma being the most common in children and young adults. It may be de nove, radiation-induced or associated with...

  • Sarcoma fibromixoide del rene.  // Urologia;2010, Vol. 77 Issue 4, p263 

    No abstract available.

  • Evidence and clinical outcomes of adult soft tissue sarcomas of the extremities treated with adjuvant high-dose-rate brachytherapy -- a literature review. Assis Pellizzon, Antonio C├íssio // Journal of Contemporary Brachytherapy;2014, Vol. 6 Issue 3, p318 

    The treatment strategies for adult soft tissue sarcomas of the extremities place an emphasis on local control, maintenance of limb function, and quality of life. Surgery is the mainstay of treatment for soft tissue sarcomas. Radiotherapy and chemotherapy are also both important treatments used...

  • Outcomes and toxicity of radiotherapy for refractory bone and soft tissue sarcomas. HIROSHI DOI; RYOONG-JIN OH; HIDEHARU MIURA; NORIHISA MASAI; HIROYA SHIOMI; TOSHIHIKO INOUE // Molecular & Clinical Oncology;Jan2016, Vol. 4 Issue 1, p83 

    Surgical resection is a well-established treatment option for sarcoma. However, anatomical barriers often hamper radical surgical procedures. The treatment of unresectable sarcoma, including local or distant failures following initial treatment, is challenging. The aim of the present study was...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics